Tarsus Pharmaceuticals
TARS
TARS
245 hedge funds and large institutions have $3.61B invested in Tarsus Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 52 funds opening new positions, 84 increasing their positions, 85 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
1% less repeat investments, than reductions
Existing positions increased: 84 | Existing positions reduced: 85
2.57% less ownership
Funds ownership: 106.35% → 103.77% (-2.6%)
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
Holders
245
Holding in Top 10
5
Calls
$27.3M
Puts
$671K
Top Buyers
| 1 | +$46.7M | |
| 2 | +$36.7M | |
| 3 | +$23.5M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$16.6M |
| 5 |
RI
RTW Investments
New York
|
+$11.8M |
Top Sellers
| 1 | -$94.5M | |
| 2 | -$49.5M | |
| 3 | -$32.8M | |
| 4 |
Jennison Associates
New York
|
-$28M |
| 5 |
CFM
Capricorn Fund Managers
London,
United Kingdom
|
-$16.3M |
